Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct complex organic molecules. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). Commonly employed in the preparation of kinase inhibitors and other bioactive compounds in medicinal chemistry research. Also utilized in the synthesis of novel pyrimidine derivatives for drug discovery programs targeting cancer and inflammatory diseases.